Vaccine breakthrough infections in a highly-vaccinated Australian population during a SARS-CoV-2 Delta outbreak

被引：4

作者：

Sheel, Meru ^{[1
,2
,3
]}

Voo, Tze Vun ^{[1
]}

Pingault, Nevada ^{[1
]}

Sloan-Gardner, Timothy S. ^{[1
]}

Marmor, Alexandra ^{[1
]}

Kirk, Martyn D. ^{[2
]}

Johnston, Vanessa ^{[1
]}

Coleman, Kerryn ^{[1
]}

机构：

[1] ACT Hlth, Publ Hlth Emergency Coordinat Ctr, Canberra, ACT, Australia

[2] Australian Natl Univ, ANU Coll Hlth & Med, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT, Australia

[3] Univ Sydney, Fac Hlth & Med, Sydney Sch Publ Hlth, Camperdown, NSW, Australia

来源：

COMMUNICABLE DISEASES INTELLIGENCE | 2022年 / 46卷

基金：

英国医学研究理事会;

关键词：

COVID-19 breakthrough infections; Australian Capital Territory; COVID-; 9; outbreak; SARS-CoV-2; Delta; vaccination;

D O I：

10.33321/cdi.2022.46.32

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Over 80% of residents in the Australian Capital Territory were fully vaccinated within 10 weeks of a SARS-CoV-2 Delta variant outbreak. Of the outbreak's 1,545 cases, 10% were breakthrough infections. The incidence of infections among fully- and partially-vaccinated people was 98.5% and 90% lower, respectively, than for unvaccinated people.

引用

页数：8

共 50 条

[31] SARS-CoV-2 breakthrough infections in vaccinated kidney transplant recipients: an issue of concern
Wijtvliet, Veerle
Ledeganck, Kristien
Peeters, Bart
Hellemans, Rachel
Abramowicz, Daniel
CLINICAL KIDNEY JOURNAL, 2021, 14 (10) : 2261 - 2262
[32] Publisher Correction: Clinical characteristics and immune profile alterations in vaccinated individuals with breakthrough Delta SARS-CoV-2 infections
Qinghong Fan
Jingrong Shi
Yanhong Yang
Guofang Tang
Mengling Jiang
Jiaojiao Li
Jingyan Tang
Lu Li
Xueliang Wen
Lieguang Zhang
Xizi Deng
Yaping Wang
Yun Lan
Liya Li
Ping Peng
Yuwei Tong
Huan Lu
Lili Yan
Ying Liu
Shuijiang Cai
Yueping Li
Xiaoneng Mo
Meiyu Li
Xilong Deng
Zhongwei Hu
Haisheng Yu
Fengyu Hu
Jinxin Liu
Xiaoping Tang
Feng Li
Nature Communications, 13
[33] Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infections
Abu-Raddad, Laith J.
Chemaitelly, Hiam
Ayoub, Houssein H.
Tang, Patrick
Coyle, Peter
Hasan, Mohammad R.
Yassine, Hadi M.
Benslimane, Fatiha M.
Al-Khatib, Hebah A.
Al-Kanaani, Zaina
Al-Kuwari, Einas
Jeremijenko, Andrew
Kaleeckal, Anvar Hassan
Latif, Ali Nizar
Shaik, Riyazuddin Mohammad
Abdul-Rahim, Hanan F.
Nasrallah, Gheyath K.
Al-Kuwari, Mohamed Ghaith
Butt, Adeel A.
Al-Romaihi, Hamad Eid
Al-Khal, Abdullatif
Al-Thani, Mohametabd H.
Bertollini, Roberto
NATURE COMMUNICATIONS, 2022, 13 (01)
[34] Relative infectiousness of SARS-CoV-2 vaccine breakthrough infections, reinfections, and primary infections
Laith J. Abu-Raddad
Hiam Chemaitelly
Houssein H. Ayoub
Patrick Tang
Peter Coyle
Mohammad R. Hasan
Hadi M. Yassine
Fatiha M. Benslimane
Hebah A. Al-Khatib
Zaina Al-Kanaani
Einas Al-Kuwari
Andrew Jeremijenko
Anvar Hassan Kaleeckal
Ali Nizar Latif
Riyazuddin Mohammad Shaik
Hanan F. Abdul-Rahim
Gheyath K. Nasrallah
Mohamed Ghaith Al-Kuwari
Adeel A. Butt
Hamad Eid Al-Romaihi
Abdullatif Al-Khal
Mohametabd H. Al-Thani
Roberto Bertollini
Nature Communications, 13
[35] Immunosuppression and SARS-CoV-2 breakthrough infections
Kim, Alfred H. J.
Sparks, Jeffrey A.
LANCET RHEUMATOLOGY, 2022, 4 (06): : E379 - E380
[36] Effectiveness of the mRNA-1273 Vaccine during a SARS-CoV-2 Delta Outbreak in a Prison
Chin, Elizabeth T.
Leidner, David
Zhang, Yifan
Long, Elizabeth
Prince, Lea
Li, Ying
Andrews, Jason R.
Studdert, David M.
Goldhaber-Fiebert, Jeremy D.
Salomon, Joshua A.
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (24): : 2300 - 2301
[37] Multistate Outbreak of SARS-CoV-2 Infections, Including Vaccine Breakthrough Infections, Associated with Large Public Gatherings, United States
Gharpure, Radhika
Sami, Samira
Vostok, Johanna
Johnson, Hillary
Hall, Noemi
Foreman, Anne
Sabo, Rebecca T.
Schubert, Petra L.
Shephard, Hanna
Brown, Vance R.
Brumfield, Ben
Ricaldi, Jessica N.
Conley, Andrew B.
Zielinski, Lindsay
Malec, Lenka
Newman, Alexandra P.
Chang, Michelle
Finn, Lauren E.
Stainken, Cameron
Mangla, Anil T.
Eteme, Patrick
Wieck, Morgan
Green, Alison
Edmundson, Alexandra
Reichbind, Diana
Brown, Vernell, Jr.
Quinones, Laura
Longenberger, Allison
Hess, Elke
Gumke, Megan
Manion, Alicia
Thomas, Hannah
Barrios, Carla A.
Koczwara, Adrianna
Williams, Thelonious W.
Pearlowitz, Marcia
Assoumou, Moussokoura
Pajares, Alessandra F. Senisse
Dishman, Hope
Schardin, Cody
Wang, Xiong
Stephens, Kendalyn
Moss, Nakema S.
Singh, Gurpalik
Feaster, Christine
Webb, Lindsey Martin
Krueger, Anna
Dickerson, Kristen
Dewart, Courtney
Barbeau, Bree
EMERGING INFECTIOUS DISEASES, 2022, 28 (01) : 35 - 43
[38] Transmission from vaccinated individuals in a large SARS-CoV-2 Delta variant outbreak
Siddle, Katherine J.
Krasilnikova, Lydia A.
Moreno, Gage K.
Schaffner, Stephen F.
Vostok, Johanna
Fitzgerald, Nicholas A.
Lemieux, Jacob E.
Barkas, Nikolaos
Loreth, Christine
Specht, Ivan
Tomkins-Tinch, Christopher H.
Paull, Jillian S.
Schaeffer, Beau
Taylor, Bradford P.
Loftness, Bryn
Johnson, Hillary
Schubert, Petra L.
Shephard, Hanna M.
Doucette, Matthew
Fink, Timelia
Lang, Andrew S.
Baez, Stephanie
Beauchamp, John
Hennigan, Scott
Buzby, Erika
Ash, Stephanie
Brown, Jessica
Clancy, Selina
Cofsky, Seana
Gagne, Luc
Hall, Joshua
Harrington, Rachel
Gionet, Gabrielle L.
DeRuff, Katherine C.
Vodzak, Megan E.
Adams, Gordon C.
Dobbins, Sabrina T.
Slack, Sarah D.
Reilly, Steven K.
Anderson, Lisa M.
Cipicchio, Michelle C.
DeFelice, Matthew T.
Grimsby, Jonna L.
Anderson, Scott E.
Blumenstiel, Brendan S.
Meldrim, James C.
Rooke, Heather M.
Vicente, Gina
Smith, Natasha L.
Messer, Katelyn S.
CELL, 2022, 185 (03) : 485 - +
[39] A study of SARS-CoV-2 delta variant breakthrough infections and side effects of the Oxford-AstraZeneca vaccine
Hussein, Nawfal R.
Rasheed, Bizav Naji
Naqid, Ibrahim A.
Dirbaz, Arshed Mustafa
Saleem, Zana Sidiq M.
Ibrahim, Nashwan
Musa, Dildar H.
Mohammed, Sulav Muslih
PUBLIC HEALTH IN PRACTICE, 2022, 4
[40] Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine breakthrough infections: a multicentre cohort study
Chia, Po Ying
Ong, Sean Wei Xiang
Chiew, Calvin J.
Ang, Li Wei
Chavatte, Jean-Marc
Mak, Tze-Minn
Cui, Lin
Kalimuddin, Shirin
Chia, Wan Ni
Tan, Chee Wah
Chai, Louis Yi Ann
Tan, Seow Yen
Zheng, Shuwei
Lin, Raymond Tzer Pin
Wang, Linfa
Leo, Yee-Sin
Lee, Vernon J.
Lye, David Chien
Young, Barnaby Edward
CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (04) : 612.e1 - 612.e7

← 1 2 3 4 5 →